Literature DB >> 30462807

Thyroid cancer burden and economic impact on the Brazilian public health system.

Carolina Castro Porto Silva Janovsky1,2, Marcio Sommer Bittencourt2,3, Maykon Anderson Pires de Novais4, Rui M B Maciel1, Rosa Paula M Biscolla1, Paola Zucchi4.   

Abstract

OBJECTIVE: Recent data indicates an increasing incidence of thyroid cancer not accompanied by a proportional increase in mortality, suggesting overdiagnosis, which may represent a big public health problem, particularly where resources are scarce. This article aims to describe and evaluate the procedures related to investigation of thyroid nodules and treatment and follow-up of thyroid cancer and the costs for the Brazilian public health system between 2008 and 2015.
MATERIALS AND METHODS: Data on procedures related to investigation of thyroid nodules and treatment/follow-up of thyroid cancer between 2008 and 2015 in Brazil were collected from the Department of Informatics of the Brazilian Unified Health System (Datasus) website.
RESULTS: A statistically significant increase in the use of procedures related to thyroid nodules investigation and thyroid cancer treatment and follow-up was observed in Brazil, though a reduction was noted for procedures related to the treatment of more aggressive thyroid cancer, such as total thyroidectomy with neck dissection and higher radioiodine activities such as 200 and 250 milicuries (mCi). The procedures related to thyroid nodules investigation costs increased by 91% for thyroid ultrasound (p = 0.0003) and 128% in thyroid nodule biopsy (p < 0.001). Costs related to treatment and follow-up related-procedures increased by 120%.
CONCLUSION: The increase in the incidence of thyroid cancer in Brazil is directly associated with an increased use of diagnostic tools for thyroid nodules, which leads to an upsurge in thyroid cancer treatment and followup-related procedures. These data suggest that substantial resources are being used for diagnosis, treatment and follow-up of a potentially indolent condition.

Entities:  

Mesh:

Year:  2018        PMID: 30462807     DOI: 10.20945/2359-3997000000074

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  7 in total

1.  Healthcare expenditures among community-dwelling adults with thyroid cancer in the United States: A propensity score matched analysis.

Authors:  Sandipan Bhattacharjee; Moteb Khobrani; Ziyad Alrabiah; Jawad Bilal; Irbaz Bin Riaz
Journal:  Heliyon       Date:  2019-06-24

2.  Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.

Authors:  Vanessa Milani; Ana Laura de Sene Amâncio Zara; Everton Nunes da Silva; Larissa Barbosa Cardoso; Maria Paula Curado; Rejane Faria Ribeiro-Rotta
Journal:  PLoS One       Date:  2021-02-17       Impact factor: 3.240

3.  Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.

Authors:  Paola Solis-Pazmino; Jorge Salazar-Vega; Eddy Lincango-Naranjo; Cristhian Garcia; Gabriela Jaramillo Koupermann; Esteban Ortiz-Prado; Tannya Ledesma; Tatiana Rojas; Benjamin Alvarado-Mafla; Cesar Carcamo; Oscar J Ponce; Juan P Brito
Journal:  BMC Cancer       Date:  2021-01-08       Impact factor: 4.430

4.  Incidence of thyroid carcinomas in an extended retrospective study of 526 autopsies.

Authors:  Iuliana Sobaru Mohorea; Bogdan Socea; Dragoş Şerban; Zenaida Ceausu; Adrian Tulin; Violeta Melinte; Mihai Ceausu
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

5.  Cytomorphological study of thyroid carcinoma.

Authors:  Iuliana Mohorea; Dana Terzea; Daniela Mihalache; Bogdan Socea; Dragoş Şerban; Mihai Ceausu
Journal:  Exp Ther Med       Date:  2021-12-06       Impact factor: 2.447

6.  A Single-Center Retrospective Study of the Impact of Thyroid Cancer on the Malignant Risk of Contralateral TI-RADS 3 and 4 Nodules.

Authors:  Huan Liu; Jun Jin; Qiao Chen; Zhongmin Li
Journal:  Int J Endocrinol       Date:  2021-10-07       Impact factor: 3.257

Review 7.  Differentiated Thyroid Cancer: A Health Economic Review.

Authors:  Klaas Van Den Heede; Neil S Tolley; Aimee N Di Marco; Fausto F Palazzo
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.